Microalbuminuria is closely related to diabetic macroangiopathy

Diabetes Research and Clinical Practice

Volumn 44, Issue 1, 1999, Pages 35-40

  Sasaki, Akinori ^a   Oikawa, Shinichi ^a   Toyota, Takayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Albuminuria; Diabetic macroangiopathy; Non insulin dependent diabetes mellitus; Transferrinuria

Indexed keywords

ALBUMIN; CREATININE; TRANSFERRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; ELECTROCARDIOGRAPHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; TRANSFERRIN;

EID: 0032832928     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00014-5     Document Type: Article

References (31)

1. Parving H.H., Oxenboll B., Svendsen P.A., Sandhal-Christiansen J., Andersen A.R. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol. 100:1982;550-555.
2. Mogensen C.E., Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. N. Engl. J. Med. 311:1984;89-93.
3. Viberti G.C., Jarrett R.J., Mahmud U., Hill R.D., Argyropoulos A., Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1:1982;1430-1432.
4. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N. Engl. J. Med. 310:1984;356-360.
5. Mattock M.B., Keen H., Viberti G.C. et al. Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 31:1988;82-87.
6. Haffner S.M., Stern M.P., Gruber M.K., Hazuda H.P., Mitchell B.D., Patterson J.K. Microalbuminuria: potential marker for cardiovascular risk factors in non-diabetic subjects? Arteriosclerosis. 10:1990;727-731.
7. Miettinen H., Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-diabetic and non-insulin-dependent diabetic subjects. Stroke. 27:1996;2033-2039.
8. Haffner S.M., Morales P.A., Gruber M.K., Hazuda H.P., Stern M.P. Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arterioscler. Thromb. 13:1993;205-210.
9. Parthasarathy N., Spiro R.G. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes. 31:1982;738-741.
10. O'Donnell M.J., Martin P., Florkowski C.M. et al. Urinary transferrin excretion in type I (insulin-dependent) diabetes mellitus. Diabetic Med. 8:1991;657-661.
11. Bernard A.M., Ouled Amor A.A., Goemaere-Vanneste J. et al. Microtransferrinuria is a more sensitive indicator of early glomerular damage in diabetes than microalbuminuria. Clin. Chem. 34:1988;1920-1921.
12. McCormick C.P., Konen J.C., Shihabi Z.K. Microtransferrinuria and microalbuminuria. I. In the diabetic human. Clin. Physiol. Biochem. 8:1990;53-58.
13. Konen J., Shihabi Z., Newman J. The association of non-insulin-dependent diabetes mellitus and hypertension with urinary excretion of albumin and transferrin. Am. J. Kidney Dis. 22:1993;791-797.
14. Teppo A.M., Groop L. Urinary excretion of plasma proteins in diabetic subjects. Diabetes. 34:1985;589-594.
15. Cheung C.K., Cockram C.S., Yeung V.T., Swaminathan R. Urinary excretion of transferrin by non-insulin-dependent diabetics: a marker for early complications? Clin. Chem. 35:1989;1672-1674.
16. Bernard A., China K.S., Lauwerys R. Latex immunoassay of transferrin in urine. J. Immunol. Methods. 144:1991;49-55.
17. Teppo A.M. Immunoturbidimetry of albumin and immunoglobulin G in urine. Clin. Chem. 28:1982;1359-1361.
18. Jaffe M. Ueber den Niederschlag, welchen Pikrinsaure in normalen Harn erzeugt und uber eine neue Reaktion des Kreatinins. Hoppe Seylers Z. Physiol. Chem. 10:1886;391-400.
19. Bennett P.H., Haffner S., Kasiske B.L. et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am. J. Kidney Dis. 25:1995;107-112.
20. Yudkin J.S., Forrest R.D., Jackson C.A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet. II:1988;530-533.
21. Damsgaard E.L., Frøland A., Jørgensen O.D., Mogensen C.E. Eight to nine year mortality in known non-insulin-dependent diabetes and controls. Kidney Int. 41:1992;731-735.
22. Mattock M.B., Morrish N.J., Viberti G., Keen H., Fitzgerald A.P., Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 41:1992;736-741.
23. McCormick C.P., Shihabi Z.K., Konen J.C. Microtransferrinuria and microalbuminuria: enhanced immunoassay. Ann. Clin. Lab. Sci. 19:1989;444-451.
24. Tetsutani T., Yamaguchi T., Kadono K., Iida R., Yasunaga K. Early detection of diabetic nephropathy and criteria for the initiation of therapy. Nephron. 64:1993;69-74.
25. 2-microglobulin, orosomucoid, albumin, transferrin and immunoglobulin G in urine by enzyme-linked immunosorbent assays (ELISA). Scand. J. Clin. Invest. 50:1990;843-849.
26. Magnotti R.A., Stephens G.W., Rogers R.K., Pesce A.J. Microplate measurement of urinary albumin and creatinine. Clin. Chem. 5:1989;1371-1375.
27. Rohrbach D.H., Hassel J.R., Kleinman H.K., Martin G.R. Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice. Diabetes. 31:1982;185-188.
28. Myers B.D., Winetz J.A., Chui F., Michaels A.S. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function. Kidney Int. 21:1982;633-641.
29. Vernier R.L., Steffes M.W., Sisson-Ross S., Mauer S.M. Heparan sulfate proteoglycan in the glomerular basement membrane in type I diabetes mellitus. Kidney Int. 41:1992;1070-1080.
30. Fischer V.W. Modification of anionic sites in myocardial capillary basal laminae of diabetic rats. Microvasc. Res. 37:1989;42-52.
31. McCarty M.F. Glucosamine may retard atherogenesis by promoting endothelial production of heparan sulfate proteoglycans. Med. Hypotheses. 48:1997;245-251.